TD Cowen raised the firm’s price target on Cigna (CI) to $386 from $380 and keeps a Buy rating on the shares. The firm said after the Q1 beat and raise, they remain positive on the shares, given strength in specialty growth and favorable trends in the company’s HC’s commercial LOBs.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna price target raised to $374 from $348 at Piper Sandler
- Cigna price target raised to $390 from $379 at Morgan Stanley
- Cigna price target raised to $407 from $395 at BofA
- Cigna’s Strategic Innovations and Financial Resilience Justify Buy Rating
- Cigna price target raised to $382 from $339 at Barclays